ISBN: 9798173124241 - restless legs syndrome: what changed — when the medication starts to fail, the iron test nobody offers, and the 2025 guidelines that reversed twenty years of practice (6 resultados)

ISBN: 
Refinar con la Búsqueda avanzada

Filtrar la búsqueda

  • Libros (6)

  • Nuevo (6)

a

Intervalo de precios personalizado (EUR)

a

  • Idioma: Inglés

    Editorial: Amazon Digital Services LLC - Kdp Sep 2026, 2026

    9798173124241

    Serie: Libro 2 de 5 - Neurology, Plainly

    • Tapa blanda

    Librería: AHA-BUCH GmbH, Einbeck, AlemaniaAHA-BUCH GmbH

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 27,66

    Envío por EUR 35,00 
    Se envía de Alemania a Estados Unidos de America

    Cantidad disponible: 2 disponibles

    Taschenbuch. Condición: Neu. Neuware - In January 2025, the guidelines reversed. Most patients have not been told.For twenty years, the first drug offered for restless legs syndrome was a dopamine agonist. In 2025 the American Academy of Sleep Medicine issued a clinical practice guideline that recommends against using them as standard first-line treatment - and recommends, instead, the alpha-2-delta ligands and intravenous iron.Millions of people are still taking the older drugs. Many of them are getting worse and have been told it is their condition progressing. Often it is not. It is augmentation: the medication itself driving the symptoms earlier into the day, into the arms, into the hours when they used to be free.This book is a neurologist's explanation of what changed, why it changed, and what to do about it - written for the person living with it, not for the clinic.Inside: - The five criteria that make the diagnosis, and the conditions that get mistaken for it- What augmentation looks like from the inside, and the questions that distinguish it from ordinary worsening- Why a ferritin result marked normal by the laboratory can still be too low for restless legs - and why the thresholds moved again in 2026- What the 2025 guideline actually recommends, and what it recommends against- The medications, supplements, and over-the-counter sleep aids that quietly make it worse- Peroneal nerve stimulation, compression, exercise, and the folklore - sorted by evidence, with the manufacturer-funding caveats stated plainly- Surgery, pregnancy, dialysis, long flights: the situations nobody prepares you for- For the partner who has not slept properly in years- Printable forms, a glossary, an index, and a page of questions to take to your appointmentThis book contains no doses and no tapering schedules. That is deliberate. Those decisions depend on your examination, your blood results, and everything else you take. What this book gives you is the ability to walk into an appointment knowing what to ask.Tae Ho Guak, MD is a neurologist with twenty-five years in practice and a member of the American Academy of Sleep Medicine.Educational only. Not medical advice. Do not stop a dopamine agonist abruptly.…

  • Idioma: Inglés

    Editorial: Independently Published, 2026

    9798173124241

    Serie: Libro 2 de 5 - Neurology, Plainly

    • Tapa blanda
    • Impresión bajo demanda

    Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de AmericaGrand Eagle Retail

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 20,71

     Gastos de envío gratis 
    Se envía dentro de Estados Unidos de America

    Cantidad disponible: 1 disponible

    Paperback. Condición: new. Paperback. In January 2025, the guidelines reversed. Most patients have not been told.For twenty years, the first drug offered for restless legs syndrome was a dopamine agonist. In 2025 the American Academy of Sleep Medicine issued a clinical practice guideline that recommends against using them as standard first-line treatment - and recommends, instead, the alpha-2-delta ligands and intravenous iron.Millions of people are still taking the older drugs. Many of them are getting worse and have been told it is their condition progressing. Often it is not. It is augmentation: the medication itself driving the symptoms earlier into the day, into the arms, into the hours when they used to be free.This book is a neurologist's explanation of what changed, why it changed, and what to do about it - written for the person living with it, not for the clinic.Inside: The five criteria that make the diagnosis, and the conditions that get mistaken for itWhat augmentation looks like from the inside, and the questions that distinguish it from ordinary worseningWhy a ferritin result marked normal by the laboratory can still be too low for restless legs - and why the thresholds moved again in 2026What the 2025 guideline actually recommends, and what it recommends againstThe medications, supplements, and over-the-counter sleep aids that quietly make it worsePeroneal nerve stimulation, compression, exercise, and the folklore - sorted by evidence, with the manufacturer-funding caveats stated plainlySurgery, pregnancy, dialysis, long flights: the situations nobody prepares you forFor the partner who has not slept properly in yearsPrintable forms, a glossary, an index, and a page of questions to take to your appointmentThis book contains no doses and no tapering schedules. That is deliberate. Those decisions depend on your examination, your blood results, and everything else you take. What this book gives you is the ability to walk into an appointment knowing what to ask.Tae Ho Guak, MD is a neurologist with twenty-five years in practice and a member of the American Academy of Sleep Medicine.Educational only. Not medical advice. Do not stop a dopamine agonist abruptly. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

  • Idioma: Inglés

    Editorial: Amazon Digital Services LLC - Kdp, 2026

    9798173124241

    • Tapa blanda
    • Impresión bajo demanda

    Librería: PBShop.store US, Wood Dale, IL, Estados Unidos de AmericaPBShop.store US

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 20,72

     Gastos de envío gratis 
    Se envía dentro de Estados Unidos de America

    Cantidad disponible: Más de 20 disponibles

    PAP. Condición: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

  • Idioma: Inglés

    Editorial: Independently published, 2026

    9798173124241

    Serie: Libro 2 de 5 - Neurology, Plainly

    • Tapa blanda
    • Impresión bajo demanda

    Librería: California Books, Miami, FL, Estados Unidos de AmericaCalifornia Books

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 20,31

    Envío por EUR 2,69 
    Se envía dentro de Estados Unidos de America

    Cantidad disponible: Más de 20 disponibles

    Condición: New. Print on Demand.

  • Idioma: Inglés

    Editorial: Amazon Digital Services LLC - Kdp, 2026

    9798173124241

    Serie: Libro 2 de 5 - Neurology, Plainly

    • Tapa blanda
    • Impresión bajo demanda

    Librería: PBShop.store UK, Fairford, GLOS, Reino UnidoPBShop.store UK

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 19,13

    Envío por EUR 3,93 
    Se envía de Reino Unido a Estados Unidos de America

    Cantidad disponible: Más de 20 disponibles

    PAP. Condición: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

  • Idioma: Inglés

    Editorial: Independently Published, 2026

    9798173124241

    • Tapa blanda
    • Impresión bajo demanda

    Librería: CitiRetail, Stevenage, Reino UnidoCitiRetail

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 23,37

    Envío por EUR 44,20 
    Se envía de Reino Unido a Estados Unidos de America

    Cantidad disponible: 1 disponible

    Paperback. Condición: new. Paperback. In January 2025, the guidelines reversed. Most patients have not been told.For twenty years, the first drug offered for restless legs syndrome was a dopamine agonist. In 2025 the American Academy of Sleep Medicine issued a clinical practice guideline that recommends against using them as standard first-line treatment - and recommends, instead, the alpha-2-delta ligands and intravenous iron.Millions of people are still taking the older drugs. Many of them are getting worse and have been told it is their condition progressing. Often it is not. It is augmentation: the medication itself driving the symptoms earlier into the day, into the arms, into the hours when they used to be free.This book is a neurologist's explanation of what changed, why it changed, and what to do about it - written for the person living with it, not for the clinic.Inside: The five criteria that make the diagnosis, and the conditions that get mistaken for itWhat augmentation looks like from the inside, and the questions that distinguish it from ordinary worseningWhy a ferritin result marked normal by the laboratory can still be too low for restless legs - and why the thresholds moved again in 2026What the 2025 guideline actually recommends, and what it recommends againstThe medications, supplements, and over-the-counter sleep aids that quietly make it worsePeroneal nerve stimulation, compression, exercise, and the folklore - sorted by evidence, with the manufacturer-funding caveats stated plainlySurgery, pregnancy, dialysis, long flights: the situations nobody prepares you forFor the partner who has not slept properly in yearsPrintable forms, a glossary, an index, and a page of questions to take to your appointmentThis book contains no doses and no tapering schedules. That is deliberate. Those decisions depend on your examination, your blood results, and everything else you take. What this book gives you is the ability to walk into an appointment knowing what to ask.Tae Ho Guak, MD is a neurologist with twenty-five years in practice and a member of the American Academy of Sleep Medicine.Educational only. Not medical advice. Do not stop a dopamine agonist abruptly. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…